Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (98)
Leukemia (45)
Pediatric Research (8)
British Journal of Cancer (3)
Blood Cancer Journal (2)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (118)
Special Features (18)
Correspondence (10)
Reviews (10)
Amendments and Corrections (4)
Comments & Opinion (2)
Editorial (1)
News (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biological techniques
Biomarkers
Biotechnology
Cancer
Cell biology
Chemical biology
Diseases
Drug discovery
Health care
Immunology
Medical research
Molecular biology
Oncology
Risk factors
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 51–100 of 164 results

Advanced filters: Author: D Niederwieser Clear advanced filters

Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome

V Runde
T de Witte
J Apperley
Research05 Mar 1998
Bone Marrow Transplantation

Volume: 21, P: 255-261
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation

N Schmitz
A Bacigalupo
A Gratwohl
Research14 May 1998
Bone Marrow Transplantation

Volume: 21, P: 995-1003
Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2

D Nachbaur
G Kropshofer
D Niederwieser
Research01 Jun 1997
Bone Marrow Transplantation

Volume: 19, P: 1261-1263
A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2

P Correale
L Micheli
G Francini
ResearchOpen Access27 Nov 2001
British Journal of Cancer

Volume: 85, P: 1722-1730
Polychemotherapy combined with G-CSF-mobilized donor buffy coat transfusion for granulocytic sarcoma after allogeneic BMT for AML

D Nachbaur
H-C Duba
D Niederwieser
Research01 May 1997
Bone Marrow Transplantation

Volume: 19, P: 947-949
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)

M Aoudjhane
M Labopin
V Rocha
Research29 Sept 2005
Leukemia

Volume: 19, P: 2304-2312
Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA

Christopher J. Walker
Christopher C. Oakes
Clara D. Bloomfield
Research05 Oct 2018
Leukemia

Volume: 33, P: 771-775
Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib

N Jaekel
G Behre
H K Al-Ali
Research02 Dec 2013
Bone Marrow Transplantation

Volume: 49, P: 179-184
Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms’ tumor

K Maurer
A Heitger
D Niederwieser
Research01 Dec 1997
Bone Marrow Transplantation

Volume: 20, P: 1111-1113
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation

M van Gelder
L C de Wreede
J Schetelig
Research12 Dec 2016
Bone Marrow Transplantation

Volume: 52, P: 372-380
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial

S Iacobelli
L C de Wreede
G Gahrton
Research26 Jan 2015
Bone Marrow Transplantation

Volume: 50, P: 505-510
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation

M Stelljes
A van Biezen
T Ruutu
Research25 Aug 2008
Bone Marrow Transplantation

Volume: 42, P: 739-742
Value of liver elastography and abdominal ultrasound for detection of complications of allogeneic hemopoietic SCT

T Karlas
J Weber
V Keim
Research07 Apr 2014
Bone Marrow Transplantation

Volume: 49, P: 806-811
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus

P Dreger
P Corradini
E Montserrat
Research16 Nov 2006
Leukemia

Volume: 21, P: 12-17
Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin

T Wetzig
M Sticherling
H K Al-Ali
Research24 Jan 2005
Bone Marrow Transplantation

Volume: 35, P: 515-519
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome

N Kröger
R Brand
T de Witte
Research21 Nov 2005
Bone Marrow Transplantation

Volume: 37, P: 183-189
Stem cell transplantation from identical twins in patients with myelodysplastic syndromes

N Kröger
R Brand
T de Witte
Research08 Nov 2004
Bone Marrow Transplantation

Volume: 35, P: 37-43
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry

M Michallet
M Sobh
P Dreger
Research12 Aug 2010
Leukemia

Volume: 24, P: 1725-1731
High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML)

T Köhler
C Schill
D Niederwieser
Research24 Jan 2002
Leukemia

Volume: 16, P: 22-29
Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host disease

U Banning
T Lange
D Körholz
Research07 Feb 2005
Bone Marrow Transplantation

Volume: 35, P: 691-697
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation

T Ruutu
A van Biezen
T de Witte
Research12 Mar 2012
Bone Marrow Transplantation

Volume: 47, P: 1459-1464
A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

H K Al-Ali
R Brand
T de Witte
Research05 Jul 2007
Leukemia

Volume: 21, P: 1945-1951
The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT

S Giebel
M Labopin
V Rocha
Research09 Jul 2012
Bone Marrow Transplantation

Volume: 48, P: 238-242
MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia

Jens-Uwe Hartmann
Daniela Bräuer-Hartmann
Gerhard Behre
ResearchOpen Access26 Jul 2018
Cell Death & Disease

Volume: 9, P: 1-16
Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis

P Dreger
R Brand
D Niederwieser
Research14 Apr 2005
Leukemia

Volume: 19, P: 1029-1033
Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors

W Hilbe
W Nussbaumer
D Nachbaur
Research10 Oct 2000
Bone Marrow Transplantation

Volume: 26, P: 811-813
Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation

T de Witte
F Pikkemaat
J Apperley
Research29 Nov 2001
Leukemia

Volume: 15, P: 1878-1884
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT

Y Chalandon
J R Passweg
C Guglielmi
Research27 Jul 2009
Bone Marrow Transplantation

Volume: 45, P: 558-564
Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens

M Deininger
W Pönisch
D Niederwieser
Research06 Jul 2001
Bone Marrow Transplantation

Volume: 27, P: 1125-1132
Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres

P Windrum
T C M Morris
T Ruutu
Research25 Jul 2005
Bone Marrow Transplantation

Volume: 36, P: 601-603
The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation

H K Al-Ali
M Bourgeois
D Niederwieser
Research06 Dec 2010
Bone Marrow Transplantation

Volume: 46, P: 1296-1302
OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease

S Knop
H Hebart
H Einsele
Research05 Sept 2005
Bone Marrow Transplantation

Volume: 36, P: 831-837
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML)

EFM Posthuma
JHF Falkenburg
D Niederwieser
Research28 Apr 2000
Leukemia

Volume: 14, P: 859-862
Isolated HLA-C mismatches in unrelated donor transplantation for CML

J-M Tiercy
J Passweg
E Roosnek
Research07 Jun 2004
Bone Marrow Transplantation

Volume: 34, P: 249-255
ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation

Madlen Jentzsch
Juliane Grimm
Sebastian Schwind
ResearchOpen Access19 Nov 2020
Bone Marrow Transplantation

Volume: 56, P: 936-945
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial

Richard A. Larson
Sumithra J. Mandrekar
Richard M. Stone
Research02 Mar 2021
Leukemia

Volume: 35, P: 2539-2551
Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends

Helen Baldomero
Mahmoud Aljurf
Nicolas Novitzky
Research06 Aug 2018
Bone Marrow Transplantation

Volume: 54, P: 402-417
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

Johannes Schetelig
Liesbeth C. de Wreede
Nicolaus Kröger
ResearchOpen Access20 Dec 2018
Leukemia

Volume: 33, P: 686-695
Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Peter Dreger
Mauricette Michallet
Johannes Schetelig
Research04 May 2018
Bone Marrow Transplantation

Volume: 54, P: 44-52
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

Frank G. Rücker
Ling Du
Konstanze Döhner
ResearchOpen Access28 Jul 2021
Leukemia

Volume: 36, P: 90-99
Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience

Mazyar Shadman
David G. Maloney
Mohamed L. Sorror
Research03 Sept 2019
Bone Marrow Transplantation

Volume: 55, P: 172-181
Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement

Thomas Karlas
Tina Weiße
Georg-Nikolaus Franke
Research26 Feb 2019
Bone Marrow Transplantation

Volume: 54, P: 1738-1746
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT

Thomas Heinicke
Myriam Labopin
Mohamad Mohty
Research23 Oct 2019
Bone Marrow Transplantation

Volume: 55, P: 729-739
AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation

Kazimierz Halaburda
Myriam Labopin
Arnon Nagler
Research18 Apr 2018
Bone Marrow Transplantation

Volume: 53, P: 683-691
Challenges with advanced therapy medicinal products and how to meet them

Advanced therapy medicinal products (ATMPs) offer hope for the treatment of diseases for which therapeutic options are currently lacking. This article discusses the regulatory role of the Committee for Advanced Therapies at the European Medicines Agency, highlighting issues and challenges observed in ATMP development.

Christian K. Schneider
Paula Salmikangas
Patrick Celis
Reviews01 Mar 2010
Nature Reviews Drug Discovery

Volume: 9, P: 195-201
Erratum: Latin America: the next region for haematopoietic transplant progress

G Jaimovich
J Martinez Rolon
A Seber
Amendments and Corrections03 May 2017
Bone Marrow Transplantation

Volume: 52, P: 798
Hematopoietic stem cell transplantation for hematological malignancies in Europe

A Gratwohl
H Baldomero
A Urbano-Ispizua
Research15 May 2003
Leukemia

Volume: 17, P: 941-959
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry

Hanneke C. Kluin-Nelemans
Andreas Reiter
Wolfgang R. Sperr
Research18 Nov 2019
Leukemia

Volume: 34, P: 1090-1101
Author Correction: Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement

Thomas Karlas
Tina Weiße
Georg-Nikolaus Franke
Amendments and Corrections19 Mar 2019
Bone Marrow Transplantation

Volume: 54, P: 1920
Erratum: Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

T Ruutu
A Gratwohl
D Niederwieser
Amendments and Corrections23 Dec 2013
Bone Marrow Transplantation

Volume: 49, P: 319

Previous page
page 1
page 2
page 3
page 4
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2025 Springer Nature Limited